![](/img/cover-not-exists.png)
285 Capecitabine and mitomycin C (MMC) is an active well-tolerated regimen as first line treatment for metastatic colorectal cancer (MCRC)
S. Rao, D. Cunningham, M.E. Hill, T.J. Price, P. Shellito, N. Tebbutt, A.R. Norman, J. OatesVolume:
1
Year:
2003
Language:
english
DOI:
10.1016/s1359-6349(03)90318-1
File:
PDF, 162 KB
english, 2003